Skip to main content

Table 6 Correlation between degree of clinical improvement and hemodynamic change in channel 21

From: Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy

 

MPH

ATX

ARF

−0.006

−0.196

ARI

−0.072

−0.406

ARH

−0.017

−0.087

SCWC-1

−0.331

0.147

SCWC-2

−0.213

−0.014

SCWC-3

−0.349

−0.100

  1. Tested using Spearman’s correlation test
  2. MPH methylphenidate, ATX atomoxetine, ARF ADHD RS IV-J full scores, ARI ADHD RS IV-J inattention subscale scores, ARH ADHD RS IV-J hyperactivity subscale scores, SCWC-1 Stroop color-word task number of correct answers first time, SCWC-2 Stroop color-word task number of correct answers second time, SCWC-3 Stroop color-word task number of correct answers third time
  3. All p > 0.216